NEFL and frontotemporal dementia: However, even in general circulation, NfL has been reported as a reliable surrogate biomarker of neuroaxonal injury in diverse neurological diseases, spanning from multiple sclerosis (MS) to Alzheimer’s disease (AD), frontotemporal lobar degeneration (FTLD), and traumatic brain injury [17,18,19,20,21].